A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines
CPT: Pharmacometrics & Systems Pharmacology · 2025-07 · 14 (7) · 1213-1224
DOI: 10.1002/psp4.70041 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 26.05.2025. Verfasst von Lorenzo Dasti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, RNA, Messenger, mRNA Vaccines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
The unprecedented effort to cope with the COVID‐19 pandemic has unlocked the potential of mRNA vaccines as a powerful technology, set to become increasingly pervasive in the years to come. As in other areas of drug development, mathematical modeling is a pivotal tool to support and expedite the mRNA vaccine development process. This study introduces a Quantitative Systems Pharmacology (QSP) model that captures key immune responses following mRNA vaccine administration, encompassing both tissue‐level and molecular‐level events. The model mechanistically describes the biological processes from the uptake of mRNA by antigen‐presenting cells at the injection site to the subsequent release of antibodies into the bloodstream. This two‐layer model represents a first attempt to link the molecular mechanisms leading to antigen expression with the immune response, paving the way for the future integration of specific vaccine attributes, such as mRNA sequence features and nanotechnology‐based delivery systems. Calibrated specifically for the BNT162b2 SARS‐CoV‐2 vaccine, the model has undergone successful validation across various dosing regimens and administration schedules. The results underscore the model's effectiveness in optimizing dosing strategies and highlighting critical differences in immune responses, particularly among low‐responder groups such as the elderly. Furthermore, the model's adaptability has been demonstrated through its calibration for other mRNA vaccines, such as the Moderna mRNA‐1273 vaccine, emphasizing its versatility and broad applicability in mRNA vaccine research and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
- Fondazione the Microsoft Research-University of Trento Centre for Computational and Systems Biology (COSBI), Rovereto, Italy.
- Department of Information Engineering and Computer Science, University of Trento, Trento, Italy.
- School of Biosciences, Division of Natural Sciences, University of Kent, Canterbury, UK.
- Department of Mathematics, University of Trento, Trento, Italy.
ORCID-Profile: Lorenzo Dasti, Stefano Giampiccolo, Elisa Pettinà, Giada Fiandaca, Natascia Zangani, Lorena Leonardelli, Fabio De Lima Hedayioglu, Elio Campanile, Luca Marchetti
Förderung
- Wellcome Trust
Zitieren
APA
Dasti, L., Giampiccolo, S., Pettinà, E., Fiandaca, G., Zangani, N., Leonardelli, L., Hedayioglu, F. L., Campanile, E., & Marchetti, L. (2025). A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines. CPT: Pharmacometrics & Systems Pharmacology, 14(7), 1213-1224. https://doi.org/10.1002/psp4.70041
Vancouver
Dasti L, Giampiccolo S, Pettinà E, Fiandaca G, Zangani N, Leonardelli L, et al. A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines. CPT: Pharmacometrics & Systems Pharmacology. 2025;14(7):1213-1224. doi:10.1002/psp4.70041
BibTeX
@article{Dasti2025,
author = {Dasti, Lorenzo and Giampiccolo, Stefano and Pettinà, Elisa and Fiandaca, Giada and Zangani, Natascia and Leonardelli, Lorena and Hedayioglu, Fabio De Lima and Campanile, Elio and Marchetti, Luca},
title = {A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2025},
volume = {14},
number = {7},
pages = {1213--1224},
doi = {10.1002/psp4.70041}
}
EUVIMED